BBI
GILD icon

Baxter Bros Inc’s Gilead Sciences GILD Stock Holding History

Baxter Bros Inc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,410
Closed -$263K – 113
2018
Q3 		$263K Sell
3,410
-50
-1% -$3.78K 0.06% 102
2018
Q2 		$245K Sell
3,460
-637
-16% -$45K 0.07% 101
2018
Q1 		$309K Sell
4,097
-63
-2% -$5.01K 0.08% 100
2017
Q4 		$298K Sell
4,160
-500
-11% -$38K 0.08% 103
2017
Q3 		$378K Sell
4,660
-800
-15% -$61.2K 0.11% 91
2017
Q2 		$386K Buy
5,460
+200
+4% +$13.3K 0.12% 90
2017
Q1 		$357K Sell
5,260
-1,465
-22% -$103K 0.11% 91
2016
Q4 		$482K Sell
6,725
-445
-6% -$33.1K 0.16% 83
2016
Q3 		$567K Sell
7,170
-395
-5% -$32.1K 0.19% 76
2016
Q2 		$631K Buy
+7,565
New +$671K 0.22% 73
2015
Q4 		$1.19M Buy
11,798
+3,493
+42% +$363K 0.44% 51
2015
Q3 		$972K Hold
8,305
– – 0.36% 61
2015
Q2 		$972K Buy
8,305
+1,280
+18% +$140K 0.36% 61
2015
Q1 		$689K Buy
7,025
+4,598
+189% +$467K 0.25% 68
2014
Q4 		$229K Buy
+2,427
New +$251K 0.08% 102
2014
Q1 		– Sell
-3,130
Closed -$235K – 99
2013
Q4 		$235K Buy
+3,130
New +$218K 0.11% 87

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baxter Bros Inc's GILD Position: Q4 2018 in Review

Baxter Bros Inc sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 3,410 shares — an estimated $263K sold.

Baxter Bros Inc first reported a position in GILD in Q4 2013 and held it in 16 quarters. The position peaked at $1.19M in Q4 2015. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • Baxter Bros Inc reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
  • Baxter Bros Inc sold 3,410 Gilead Sciences shares in Q4 2018, an estimated $263K.
  • Baxter Bros Inc first reported a position in Gilead Sciences in Q4 2013 and held it in 16 quarters.
  • Baxter Bros Inc's Gilead Sciences position peaked at $1.19M in Q4 2015.
  • 1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Baxter Bros Inc's 13F filing for Q4 2018, filed 22 Jan 2019.